CHALLENGING MEDICAL DERMATOLOGY CASES | A CASE-BASED CONVERSATION WITH THE EXPERTS
Just like the best movie trailers, the ODAC Virtual Pre-Conference Symposium is designed to hook your interest with just the right amount of intriguing content. This event, which we proudly consider the gateway to ODAC’s comprehensive educational experience, is now in its fifth year. Featuring an all-new lineup of faculty and cases, the virtual, case-based program will explore a wide range of complex topics in medical dermatology. So, prepare your favorite snack, settle in with your beverage of choice, and get ready for an engaging evening with moderator and ODAC co-chair Dr. Adam Friedman and our panel of distinguished experts.
Through interactive clinical cases, ODAC faculty will provide insights into the diagnosis, workup, and treatment of patients with various medical dermatology conditions, with a focus on:
- Hidradenitis Suppurativa
- Discoid Lupus
- Psoriasis
- Atopic Dermatitis
NON-CME/CE BONUS PRESENTATION
SPEAKER
AGENDA
The Latest Approved Indication for COSENTYX® (secukinumab)
Speaker: Steven Daveluy, MD, FAAD
Sponsored by Novartis
Please join Novartis for an information program to learn more about the latest approved indication for COSENTYX® (secukinumab).
FACULTY
TARGET AUDIENCE
The intended audience for this live activity includes dermatologists, dermatology residents, fellows and young practitioners, dermatology nurse practitioners and physician assistants, and other healthcare providers with an interest in treating patients with cutaneous diseases and disorders in persons of all ages and skin types.
LEARNING OBJECTIVES
After completing this activity, the participant should be better able to:
- Identify the proposed etiology of psoriasis, discoid lupus, hidradenitis suppurativa, and atopic dermatitis.
- Review the clinical features, biomarkers, diagnostic and histopathological testing required for the differential diagnosis of psoriasis, discoid lupus, hidradenitis suppurativa, and atopic dermatitis.
- Outline the pharmacologic and non-pharmacologic treatment options available for psoriasis, discoid lupus, hidradenitis suppurativa, and atopic dermatitis.
JOINT ACCREDITATION STATEMENT
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and National Medical Education Corporation. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.